Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Anti-glycan antibodies are an abundant subpopulation of serum antibodies with critical functions in many immune processes. Changes in the levels of these antibodies can occur with the onset of disease, exposure to pathogens, or vaccination. As a result, there has been significant interest in exploiting anti-glycan antibodies as biomarkers for many diseases. Serum contains a mixture of anti-glycan antibodies that can recognize the same antigen, and competition for binding can potentially influence the detection of antibody subpopulations that are more relevant to disease processes. The most abundant antibody isotypes in serum are IgG, IgM, and IgA, but little is known regarding how these different isotypes compete for the same glycan antigen. In this study, we developed a multiplexed glycan microarray assay and applied it to evaluate how different isotypes of anti-glycan antibodies (IgA, IgG, and IgM) compete for printed glycan antigens. While IgG and IgA antibodies typically outcompete IgM for peptide or protein antigens, we found that IgM outcompete IgG and IgA for many glycan antigens. To illustrate the importance of this effect, we provide evidence that IgM competition can account for the unexpected observation that IgG of certain antigen specificities appear to be preferentially transported from mothers to fetuses. We demonstrate that IgM in maternal sera compete with IgG resulting in lower than expected IgG signals. Since cord blood contains very low levels of IgM, competition only affects maternal IgG signals, making it appear as though certain IgG antibodies are higher in cord blood than matched maternal blood. Taken together, the results highlight the importance of competition for studies involving anti-glycan antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474 · cited 1×
“Due to the affinity maturation and class switching processes, IgG and IgA antibodies typically have substantially higher affinities than IgM antibodies [18,19].”
BackgroundProtein-glycan interactions in the control of innate and adaptive immune responses
van Kooyk, Y., & Rabinovich, G. A. (2008) · Nature Immunology · doi:10.1038/ni.f.203 · Cited by 807
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Molecular Mechanism of Class Switch Recombination: Linkage with Somatic Hypermutation
Honjo, T., Kinoshita, K., & Muramatsu, M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.090501.112049 · Cited by 598 · cited 1×
“Due to the affinity maturation and class switching processes, IgG and IgA antibodies typically have substantially higher affinities than IgM antibodies [18,19].”
BackgroundWatkins, W. M. (1966) · Science · doi:10.1126/science.152.3719.172 · Cited by 540
Glycan Microarrays for Decoding the Glycome
Rillahan, C. D., & Paulson, J. C. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061809-152236 · Cited by 428
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy
Springer, G. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050144 · Cited by 426
The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
Galili, U. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01366.x · Cited by 336
Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport
KOHLER, P. F., & FARR, R. S. (1966) · Nature · doi:10.1038/2101070a0 · Cited by 325
High-Mannose Glycans are Elevated during Breast Cancer Progression
de Leoz, M. L. A., Young, L. J. T., An, H. J., Kronewitter, S. R., Kim, J., Miyamoto, S., Borowsky, A. D., Chew, H. K., & Lebrilla, C. B. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002717 · Cited by 320
Glycobiology of immune responses
Rabinovich, G. A., van Kooyk, Y., & Cobb, B. A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06492.x · Cited by 279
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2893 · Cited by 266
Park, S., Gildersleeve, J. C., Blixt, O., & Shin, I. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35401b · Cited by 243
Self-citationOligosaccharide and Glycoprotein Microarrays as Tools in HIV Glycobiology
Adams, E. W., Ratner, D. M., Bokesch, H. R., McMahon, J. B., O'Keefe, B. R., & Seeberger, P. H. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.010 · Cited by 234
Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease
Dotan, I., Fishman, S., Dgani, Y., Schwartz, M., Karban, A., Lerner, A., Weishauss, O., Spector, L., Shtevi, A., Altstock, R. T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.030 · Cited by 234
Glycan arrays: recent advances and future challenges
Oyelaran, O., & Gildersleeve, J. C. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.06.021 · Cited by 224
Self-citationBlixt, O., Bueti, D., Burford, B., Allen, D., Julien, S., Hollingsworth, M., Gammerman, A., Fentiman, I., Taylor-Papadimitriou, J., & Burchell, J. M. (2011) · Breast Cancer Research · doi:10.1186/bcr2841 · Cited by 211
The Transfer of Immunity from Mother to Child
HANSON, L. Å., KOROTKOVA, M., LUNDIN, S., HÅVERSEN, L., SILFVERDAL, S., MATTSBY‐BALTZER, I., STRANDVIK, B., & TELEMO, E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06049.x · Cited by 207
Shotgun glycomics: a microarray strategy for functional glycomics
Song, X., Lasanajak, Y., Xia, B., Heimburg-Molinaro, J., Rhea, J. M., Ju, H., Zhao, C., Molinaro, R. J., Cummings, R. D., & Smith, D. F. (2011) · Nature Methods · doi:10.1038/nmeth.1540 · Cited by 190
Profiling Human Serum Antibodies with a Carbohydrate Antigen Microarray
Oyelaran, O., McShane, L. M., Dodd, L., & Gildersleeve, J. C. (2009) · Journal of Proteome Research · doi:10.1021/pr900515y · Cited by 173 · cited 1×
“The array format and assay have been described previously [76], along with analysis of reproducibility [77] and validation with numerous antibodies and lectins [78– 81].”
MethodSelf-citationReference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry.
Jolliff, C. R., Cost, K. M., Stivrins, P. C., Grossman, P. P., Nolte, C. R., Franco, S. M., Fijan, K. J., Fletcher, L. L., & Shriner, H. C. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.1.126 · Cited by 172
Manimala, J. C., Roach, T. A., Li, Z., & Gildersleeve, J. C. (2007) · Glycobiology · doi:10.1093/glycob/cwm047 · Cited by 169
Self-citationCarbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen
Huang, C.-Y., Thayer, D. A., Chang, A. Y., Best, M. D., Hoffmann, J., Head, S., & Wong, C.-H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509693102 · Cited by 166
High‐Throughput Carbohydrate Microarray Analysis of 24 Lectins
Manimala, J. C., Roach, T. A., Li, Z., & Gildersleeve, J. C. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600591 · Cited by 165
Self-citationMicroarrays with Varying Carbohydrate Density Reveal Distinct Subpopulations of Serum Antibodies
Oyelaran, O., Li, Q., Farnsworth, D., & Gildersleeve, J. C. (2009) · Journal of Proteome Research · doi:10.1021/pr9002245 · Cited by 158 · cited 2×
“Glycan arrays were fabricated as previously reported [74] except for the addition of a washable fluorescent dye to the print buffer as an indicator of successful liquid deposition and spot morphology (see S1 File).”
BackgroundMethodSelf-citationSeromic profiling of colorectal cancer patients with novel glycopeptide microarray
Pedersen, J. W., Blixt, O., Bennett, E. P., Tarp, M. A., Dar, I., Mandel, U., Poulsen, S. S., Pedersen, A. E., Rasmussen, S., Jess, P., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25778 · Cited by 136
Padler-Karavani, V., Hurtado-Ziola, N., Pu, M., Yu, H., Huang, S., Muthana, S., Chokhawala, H. A., Cao, H., Secrest, P., Friedmann-Morvinski, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4102 · Cited by 133
Self-citationCross-platform comparison of glycan microarray formats
Wang, L., Cummings, R. D., Smith, D. F., Huflejt, M. E., Campbell, C. T., Gildersleeve, J. C., Gerlach, J. Q., Kilcoyne, M., Joshi, L., Serna, S., et al. (2014) · Glycobiology · doi:10.1093/glycob/cwu019 · Cited by 124
Self-citationMeurman, O., & Ziola, B. R. (1978) · Journal of Clinical Pathology · doi:10.1136/jcp.31.5.483 · Cited by 120 · cited 1×
“Additionally, rheumatoid factors (RF, antibodies that bind to human gamma immunoglobulins) can interfere with the measurement of IgM antibodies [20,21].”
BackgroundSugar-mediated ligand–receptor interactions in the immune system
Rudd, P. M., Wormald, M. R., & Dwek, R. A. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.07.012 · Cited by 108
A High-Throughput O-Glycopeptide Discovery Platform for Seromic Profiling
Blixt, O., Cló, E., Nudelman, A. S., Sørensen, K. K., Clausen, T. M., Wandall, H. H., Livingston, P. O., Clausen, H., & Jensen, K. J. (2010) · Journal of Proteome Research · doi:10.1021/pr1005229 · Cited by 106
Anti-Glycan Antibodies as Biomarkers for Diagnosis and Prognosis
Dotan, N., Altstock, R. T., Schwarz, M., & Dukler, A. (2006) · Lupus · doi:10.1191/0961203306lu2331oa · Cited by 104
Oberli, M. A., Hecht, M.-L., Bindschädler, P., Adibekian, A., Adam, T., & Seeberger, P. H. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.009 · Cited by 100
Martin, C. E., Broecker, F., Oberli, M. A., Komor, J., Mattner, J., Anish, C., & Seeberger, P. H. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401410y · Cited by 98
Boosting Immunity to Small Tumor-Associated Carbohydrates with Bacteriophage Qβ Capsids
Yin, Z., Comellas-Aragones, M., Chowdhury, S., Bentley, P., Kaczanowska, K., BenMohamed, L., Gildersleeve, J. C., Finn, M. G., & Huang, X. (2013) · ACS Chemical Biology · doi:10.1021/cb400060x · Cited by 98
Self-citationLiao, S.-F., Liang, C.-H., Ho, M.-Y., Hsu, T.-L., Tsai, T.-I., Hsieh, Y. S. Y., Tsai, C.-M., Li, S.-T., Cheng, Y.-Y., Tsao, S.-M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312457110 · Cited by 92
ABO blood group and related antigens, natural antibodies and transplantation
Milland, J., & Sandrin, M. S. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00721.x · Cited by 90
The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome
Palma, A. S., Feizi, T., Childs, R. A., Chai, W., & Liu, Y. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.01.007 · Cited by 88
Carbohydrate recognition systems in autoimmunity
Buzás, E. I., György, B., Pásztói, M., Jelinek, I., Falus, A., & Gabius, H. (2006) · Autoimmunity · doi:10.1080/08916930601061470 · Cited by 83
Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies?
Bovin, N. V., Obukhova, P. S., Shilova, N. V., Rapoport, E. M., Popova, I. S., Navakouski, M., Unverzagt, C., Vuskovic, M. I., & Huflejt, M. E. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.02.005 · Cited by 82
Leoz, M. L. A. D., An, H. J., Kronewitter, S. R., Kim, J., Beecroft, S., Vinall, R. L., Miyamoto, S., White, R. D., Lam, K. S., & Lebrilla, C. B. (2008) · Disease Markers · doi:10.1155/2008/515318 · Cited by 78
Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
Gillard, B. K., Thomas, J. W., Nell, L. J., & Marcus, D. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3826 · Cited by 74
Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array
Jacob, F., Goldstein, D. R., Bovin, N. V., Pochechueva, T., Spengler, M., Caduff, R., Fink, D., Vuskovic, M. I., Huflejt, M. E., & Heinzelmann‐Schwarz, V. (2012) · International Journal of Cancer · doi:10.1002/ijc.26002 · Cited by 73
Palmeira, P., Costa‐Carvalho, B. T., Arslanian, C., Pontes, G. N., Nagao, A. T., & Carneiro‐Sampaio, M. M. S. (2009) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2008.00828.x · Cited by 72
Serum anti-Glc(α1,4)Glc(α) antibodies as a biomarker for relapsing–remitting multiple sclerosis
Schwarz, M., Spector, L., Gortler, M., Weisshaus, O., Glass‐Marmor, L., Karni, A., Dotan, N., & Miller, A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.12.006 · Cited by 65
van Diepen, A., Smit, C. H., van Egmond, L., Kabatereine, N. B., Pinot de Moira, A., Dunne, D. W., & Hokke, C. H. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001922 · Cited by 63
Using glycan microarrays to understand immunity
Arthur, C. M., Cummings, R. D., & Stowell, S. R. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.12.017 · Cited by 60 · cited 1×
“Recently, glycan microarray technology has emerged as a powerful high-throughput tool for profiling serum anti-glycan antibodies (for recent reviews, see [26,37,38]; for some recent examples, see [27,28,39–73]).”
BackgroundDeciphering Structural Elements of Mucin Glycoprotein Recognition
Borgert, A., Heimburg-Molinaro, J., Song, X., Lasanajak, Y., Ju, T., Liu, M., Thompson, P., Ragupathi, G., Barany, G., Smith, D. F., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300076s · Cited by 58
Burford, B., Gentry-Maharaj, A., Graham, R., Allen, D., Pedersen, J. W., Nudelman, A. S., Blixt, O., Fourkala, E. O., Bueti, D., Dawnay, A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.214 · Cited by 55
Cancer-Associated Carbohydrate Antigens as Potential Biomarkers for Hepatocellular Carcinoma
Wu, C.-S., Yen, C. J., Chou, R., Li, S.-T., Huang, W., Ren, C., Wu, C.-Y., & Yu, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039466 · Cited by 50
Glycan microarrays: Powerful tools for biomarker discovery
Muthana, S. M., & Gildersleeve, J. C. (2014) · Cancer Biomarkers · doi:10.3233/cbm-130383 · Cited by 48 · cited 1×
“Recently, glycan microarray technology has emerged as a powerful high-throughput tool for profiling serum anti-glycan antibodies (for recent reviews, see [26,37,38]; for some recent examples, see [27,28,39–73]).”
BackgroundSelf-citationBlixt, O., Kumagai-Braesch, M., Tibell, A., Groth, C. G., & Holgersson, J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02471.x · Cited by 48
Humoral response to a viral glycan correlates with survival on PROSTVAC-VF
Campbell, C. T., Gulley, J. L., Oyelaran, O., Hodge, J. W., Schlom, J., & Gildersleeve, J. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314722111 · Cited by 47
Self-citationImmunogenicity and Diagnostic Potential of Synthetic Antigenic Cell Surface Glycans of Leishmania
Anish, C., Martin, C. E., Wahlbrink, A., Bogdan, C., Ntais, P., Αντωνίου, Μ., & Seeberger, P. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400602k · Cited by 47
Serum Antibodies to Blood Group A Predict Survival on PROSTVAC-VF
Campbell, C. T., Gulley, J. L., Oyelaran, O., Hodge, J. W., Schlom, J., & Gildersleeve, J. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2478 · Cited by 47
Self-citationBlixt, O., Lavrova, O. I., Mazurov, D. V., Cló, E., Kračun, S. K., Бовин, Н. В., & Filatov, A. V. (2011) · Glycobiology · doi:10.1093/glycob/cwr178 · Cited by 47
Construction and Use of Glycan Microarrays
Campbell, C. T., Zhang, Y., & Gildersleeve, J. C. (2010) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch090228 · Cited by 46 · cited 1×
“The array format and assay have been described previously [76], along with analysis of reproducibility [77] and validation with numerous antibodies and lectins [78– 81].”
MethodSelf-citationZeng, Z., Hincapie, M., Haab, B. B., Hanash, S., Pitteri, S. J., Kluck, S., Hogan, J. M., Kennedy, J. J., & Hancock, W. S. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.09.029 · Cited by 46
Placental transfer favours high avidity IgG antibodies
Avanzini, M. A., Pignatti, P., Chirico, G., Gasparoni, A., Jalil, F., & La, H. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb00972.x · Cited by 37
Grader‐Beck, T., Boin, F., von Gunten, S., Smith, D. F., Rosen, A., & Bochner, B. S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.153130 · Cited by 37
Recent Advances and Future Challenges in Glycan Microarray Technology
de Paz, J. L., & Seeberger, P. H. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-373-8_1 · Cited by 36
Aranzamendi, C., Tefsen, B., Jansen, M., Chiumiento, L., Bruschi, F., Kortbeek, T., Smith, D. F., Cummings, R. D., Pinelli, E., & van Die, I. (2011) · Experimental Parasitology · doi:10.1016/j.exppara.2011.08.015 · Cited by 36
Plague Detection by Anti‐carbohydrate Antibodies
Anish, C., Guo, X., Wahlbrink, A., & Seeberger, P. H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201301633 · Cited by 35
Multiplex suspension array for human anti-carbohydrateantibody profiling
Pochechueva, T., Chinarev, A. A., Spengler, M., Korchagina, E., Heinzelmann-Schwarz, V. A., Bovin, N. V., & Rieben, R. (2010) · The Analyst · doi:10.1039/c0an00758g · Cited by 32
Kurtenkov, O. A., Klaamas, K., Rittenhouse‐Olson, K., Vahter, L., Sergejev, B., Miljukhina, L., & Shljapnikova, L. (2005) · PubMed · Cited by 31
GalNAcα1‐3Gal, a new prognostic marker for cervical cancer
Li, Q., Anver, M. R., Li, Z., Butcher, D. O., & Gildersleeve, J. C. (2009) · International Journal of Cancer · doi:10.1002/ijc.24716 · Cited by 31
Self-citationVuskovic, M. I., Xu, H., Bovin, N. V., Pass, H. I., & Huflejt, M. E. (2011) · International Journal of Bioinformatics Research and Applications · doi:10.1504/ijbra.2011.043771 · Cited by 30
Lonardi, E., Balog, C. I. A., Deelder, A. M., & Wuhrer, M. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.41 · Cited by 30
Prasanphanich, N. S., Luyai, A. E., Song, X., Heimburg‐Molinaro, J., Mandalasi, M., Mickum, M. L., Smith, D. F., Nyame, A. K., & Cummings, R. D. (2014) · Glycobiology · doi:10.1093/glycob/cwu027 · Cited by 28
Printed glycan array: antibodies as probed in undiluted serum and effects of dilution
Shilova, N., Navakouski, M., Khasbiullina, N., Blixt, O., & Bovin, N. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-011-9368-8 · Cited by 23
Microarray analysis of the human antibody response to synthetic Cryptosporidium glycopeptides
Heimburg‐Molinaro, J., Priest, J. W., Live, D. H., Boons, G., Song, X., Cummings, R. D., & Mead, J. R. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2013.05.012 · Cited by 23
Natural Antibodies Against Sialoglycans
Shilova, N., Huflejt, M. E., Vuskovic, M., Obukhova, P., Navakouski, M., Khasbiullina, N., Pazynina, G., Galanina, O., Bazhenov, A., & Bovin, N. (2013) · Topics in Current Chemistry · doi:10.1007/128_2013_469 · Cited by 22
Polysaccharide microarrays with a CMOS based signal detection unit
Baader, J., Klapproth, H., Bednar, S., Brandstëtter, T., Rühe, J., Lehmann, M., & Freund, I. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.01.021 · Cited by 20
N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients
Wang, D. (2012) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000218 · Cited by 18
Glycopeptide microarray for autoantibody detection in cancer
Reis, C. A., Campos, D., Osório, H., & Santos, L. L. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.30 · Cited by 15 · cited 1×
“Recently, glycan microarray technology has emerged as a powerful high-throughput tool for profiling serum anti-glycan antibodies (for recent reviews, see [26,37,38]; for some recent examples, see [27,28,39–73]).”
BackgroundSong, X., Heimburg‐Molinaro, J., Smith, D. F., & Cummings, R. D. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-349-3_11 · Cited by 14
Stevenson, D. L., Harris, A. G., Neal, K. R., & Irving, W. L. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80229-7 · Cited by 11 · cited 1×
“Additionally, rheumatoid factors (RF, antibodies that bind to human gamma immunoglobulins) can interfere with the measurement of IgM antibodies [20,21].”
BackgroundShoreibah, M., Jackson, C. L., Price, P. W., Meagher, R. B., Godwin, A. K., Cai, Q. K., & Gildersleeve, J. C. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0172 · Cited by 8 · cited 1×
“In other studies we have found that monoclonal IgM antibodies can bind very tightly to glycans on our array surface, with apparent Kd values in the low nanomolar to subnanomolar range [74,75].”
BackgroundSelf-citationKamiya, K., Arisawa, T., Goto, H., Shibayama, K., Horii, T., Hayakawa, T., & Ohta, M. (1999) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1999.tb02423.x · Cited by 7
Plasma Anti-Glycan Antibody Profiles Associated with Nickel level in Urine
Vuskovic, M. I., Barbuti, A.-M., Goldsmith-Rooney, E., GLASSMAN, L. W., Bovin, N. V., Pass, H. I., Tchou-Wong, K.-M., Chen, M., Yan, B., Niu, J., et al. (2013) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000295 · Cited by 7
Changes in the repertoire of natural antibodies caused by immunization with bacterial antigens
Shilova, N. V., Navakouski, M., Huflejt, M. E., Kuehn, A., Grunow, R., Blixt, O., & Bovin, N. V. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911070170 · Cited by 6
Research works printed but not linked: 1
- CT Campbell, 2010, Construction and use of glycan microarrays, Current Protocols in Chemical Biology, 2, 37, 10.1002/9780470559277.ch090228 · DOI
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Indeed a significant fraction of circulating Ig found in normal humans may be directed against foreign glycan antigens (971) (972) (973) .”
BackgroundMatricardi, P. M., Dal Negro, R. W., & Nisini, R. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13271 · Cited by 211
Glycan Arrays: From Basic Biochemical Research to Bioanalytical and Biomedical Applications
Geissner, A., & Seeberger, P. H. (2016) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071015-041641 · Cited by 85
Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum
Muthana, S. M., & Gildersleeve, J. C. (2016) · Scientific Reports · doi:10.1038/srep19509 · Cited by 68
“The anti-IgG reagent detects all IgG subclasses, and signals for IgM and IgG are roughly comparable on micrograms/mL level 45 .”
Self-citationWhole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins
Xia, L., Schrump, D. S., & Gildersleeve, J. C. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.10.012 · Cited by 49
Self-citation
Metadata
- Authors
- Muthana, S. M., Xia, L., Campbell, C. T., Zhang, Y., & Gildersleeve, J. C.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gildersleeve, Jeffrey C.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-25
- Volume
- 10
- Issue
- 3
- Pages
- e0119298
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4373866
- OpenAlex
- W1977905136
- Cited by
- 53
- References
- 81
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 6 · 2015: 2
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Michigan State University
- National Institutes of Health (GM62116)
- College of Engineering, Michigan State University
- National Cancer Institute (GM62116)
- National Institute of General Medical Sciences (GM 62116, U54GM062116)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- anti-glycan antibodies, IgG, IgM, IgA, glycan microarrays, maternal-fetal antibody transfer, umbilical cord blood, biomarkers
- MeSH terms
- Antibody Affinity, Antigen-Antibody Reactions, Humans, Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Polysaccharides, Biomarkers, Protein Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.